We find that both MAML2 and, albeit to a lesser extent, FRYL have the capacity to independently drive sGC expression, making them potential targets for prevention of cardiovascular disease caused by an elevated blood pressure. This evidence concerns the gene MAML2 and cardiovascular disorder.